Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial

BACKGROUND: Choroideremia is an X-linked recessive disease that leads to blindness due to mutations in the CHM gene, which encodes the Rab escort protein 1 (REP1). We assessed the effects of retinal gene therapy with an adeno-associated viral (AAV) vector encoding REP1 (AAV.REP1) in patients with th...

Descripción completa

Detalles Bibliográficos
Autores principales: MacLaren, Robert E, Groppe, Markus, Barnard, Alun R, Cottriall, Charles L, Tolmachova, Tanya, Seymour, Len, Clark, K Reed, During, Matthew J, Cremers, Frans P M, Black, Graeme C M, Lotery, Andrew J, Downes, Susan M, Webster, Andrew R, Seabra, Miguel C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Publishing Group 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171740/
https://www.ncbi.nlm.nih.gov/pubmed/24439297
http://dx.doi.org/10.1016/S0140-6736(13)62117-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171740/
https://www.ncbi.nlm.nih.gov/pubmed/24439297
http://dx.doi.org/10.1016/S0140-6736(13)62117-0

Ejemplares similares